medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Comparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression. J Crohns Colitis Hayek MA, Estevinho MM, Kayal M, Hayek OA, Armuzzi A, Burisch J, Najah Q, Jairath V, Wexner SD, Loftus EV Jr, Peyrin-Biroulet L, Danese S, Elhadi M, Magro F. PMID: 42570330 [PubMed - indexed for MEDLINE]
	Protective effects and possible mechanisms of matrine-type alkaloids (matrine and oxymatrine) in animal models of ulcerative colitis: a preclinical systematic review and meta-analysis. Front Pharmacol Lu S, Yang H, Wang S, Ye J, Huang S, Cai L. PMID: 42568705 [PubMed]
	Dietary, lifestyle, and environmental factors associated with ulcerative colitis: a systematic review and meta-analysis of observational studies. Front Nutr Wang Y, Xie T, Liao Z, He S, Zhao Y, Li Y, Kong X, Sun P. PMID: 42568405 [PubMed]
	Predictors of conversion and outcomes after conversion in laparoscopic redo ileocolic resection for Crohn's disease. Colorectal Dis Alon G, Goldenshluger M, Uchino T, Belkovsky M, Valente MA, Steele SR, Liska D, Holubar SD. PMID: 42568153 [PubMed - indexed for MEDLINE]
	Drug-Drug Interaction Risk Assessment Strategies for Biologics in Inflammatory Bowel Disease: A Literature-Based Evidence Mini-Review. Clin Transl Sci Steinbronn C, Stanley SE, Bueters T, Ait-Oudhia S. PMID: 42568100 [PubMed - indexed for MEDLINE]
	Serological Remission Defined by Anti-Integrin Î±vÎ²6 Antibody Predicts Long-Term Clinical Remission of Ulcerative Colitis. Gastro Hep Adv Oguri N, Miyoshi J, Nemoto N, Kamatsu H, Wada H, Fujima T, Ogihara R, Hibi N, Morikubo H, Mitsui T, Saito D, Hayashida M, Omori T, Matsuura M, Hisamatsu T. PMID: 42565093 [PubMed]
	Clinical study on the screening of biomarkers for Crohn's disease based on blood metabolomics. Front Gastroenterol (Lausanne) Lin T, Hu X, Yuan K, Li S, Lin P, Wang W, Cui L, Wang Y, Liu P, Yang Y. PMID: 42564013 [PubMed]
	Pharmacological management of Crohn's disease of the pouch - a phenotype-based review. Expert Opin Pharmacother Kratzer L, Sparrow MP, Ardalan Z. PMID: 42563224 [PubMed - as supplied by publisher]
	Superior Effectiveness of Upadacitinib Over Tofacitinib and Ustekinumab in Bio-Exposed Ulcerative Colitis: The TRIDENT-UC Study. Clin Gastroenterol Hepatol Camões Neves J, Costa D, Cristiano M, Portela F, Fernandes AR, Fernandes S, Gonçalves N, Paulo JP, Portugal M, Gututui M, Fernandes D, Costa C, Madureira AM, Marques J, Conde PV, Damasceno J, Guimarães A, Rebelo A, Gonçalves M, Soares J, Mendes SS, Arroja B, Gonçalves R, Leal T, GEDII (Portuguese IBD Group). PMID: 42562116 [PubMed - as supplied by publisher]
	Prevalence and risk factors of pre-neoplastic polyps in patients with ulcerative colits: a cross-sectional retrospective study. Einstein (Sao Paulo) Oliveira FC, Ayrizono MLS, Reis GFSR, Nagasako CK. PMID: 42561258 [PubMed - indexed for MEDLINE]
	Appendectomy before or after ulcerative colitis diagnosis is not associated with improved long-term outcomes: a multicenter real-world study. Inflamm Bowel Dis Desai A, Dapke K, Habib H, Hashash JG, Farraye FA. PMID: 42560773 [PubMed - as supplied by publisher]
	Emerging insights into TL1A biology may guide precision therapy for IBD. J Exp Med Pires S, Yang W, Longman RS. PMID: 42560355 [PubMed - indexed for MEDLINE]
	Fucose metabolism as a central axis linking inflammation, immunity, and cancer in the gut. Front Immunol Singh DK, Saito C, Yamaguchi Y, Cassidy OG, Nishiyama K, Huang L. PMID: 42558900 [PubMed - indexed for MEDLINE]
	Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial. J Crohns Colitis Berset IP, Lerang F, Moum B, Jahnsen J, Grimstad T, Kristensen V, Wiig H, Aabrekk T, Ness-Jenssen E, Eskeland S, Melsom E, Von Volkmann H, Huppertz-Hauss G, Torp R, Hovlid Ø, Buset M, Riise G, Horvei G, Finjord T, Jelsness-Jørgensen LP, Olsen IC, Jahnsen FL, Myklebust TÅ, Mølsæter K, Hoff DAL, Lundin KEA. PMID: 42557857 [PubMed - indexed for MEDLINE]
	Restorative versus non-restorative total proctocolectomy: Who doesn't pouch and how do they do? Colorectal Dis Khan I, Berger NG, Kanters A, Lavryk O, Lipman J, Steele SR, Liska D, Holubar SD. PMID: 42557707 [PubMed - indexed for MEDLINE]
	Integrated DIA proteomics of tissue and exudate reveals screening markers for early detection of ulcerative colitis and colorectal cancer. Clin Chim Acta Gong Q, Wang J, Ke Q, Du S, Huang S, Zhu T, Qu H, Xu R, Zhang J, Yan B, Wang J. PMID: 42556455 [PubMed - as supplied by publisher]
	Multimodal monitoring of pan-enteric mucosal healing and biologic persistence in Crohn's disease-the MILESTONE-CD prospective cohort. J Crohns Colitis Ukashi O, Albshesh A, Ungar B, Varon D, Levy H, Asher AT, Goren M, Haj O, Zlotnik A, Zimlichman E, Eliakim R, Ben-Horin S, Kopylov U. PMID: 42556333 [PubMed - indexed for MEDLINE]
	Ileostomy or Ileal Pouch Anal Anastomosis: Shared Decision-Making in the Surgical Management of Ulcerative Colitis. Clin Colon Rectal Surg Cain BT, Cohan JN. PMID: 42553934 [PubMed]
	Comparative effectiveness of adalimumab versus infliximab in children with Crohn's disease: real-world data from the prospective PIBD-SETQuality inception cohort study. Crohns Colitis 360 Vuijk SA, Klomberg RCW, Katgert E, Wessels MMS, Miele E, Cameron FL, Milovanovich ID, Muhammed R, Devadason D, Hart J, Rizopoulos D, Croft NM, de Ridder L, PIBD-SETQuality Consortium, PIBD-SETQuality Consortium. PMID: 42549261 [PubMed]
	JAK1-preferential inhibition in refractory inflammatory bowel disease: reframing upadacitinib as a strategy for rapid immune recalibration. Front Immunol Liu X, Wang Y. PMID: 42549219 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 58520

Seite 1 von 2926



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung